Biontech SENASDAQ:BNTX
- LAST PRICE118.3900
- TODAY'S CHANGE (%)-2.3300 (-1.9301%)
- Bid / Lots116.8500/ 1
- Ask / Lots122.7500/ 1
- Open / Previous Close120.4000 / 120.7200
- Day Range
- 52 Week Range
- Volume517,795
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BNTX |
|---|---|---|
| 09:32 ET | 10589 | 119.8 |
| 09:33 ET | 4204 | 119.78 |
| 09:35 ET | 725 | 119.49 |
| 09:37 ET | 3378 | 119.01 |
| 09:39 ET | 2870 | 118.58 |
| 09:42 ET | 13162 | 118.375 |
| 09:44 ET | 4263 | 118.1829 |
| 09:46 ET | 10528 | 118.69 |
| 09:48 ET | 6239 | 117.945 |
| 09:50 ET | 1500 | 118.34 |
| 09:51 ET | 2773 | 118.485 |
| 09:53 ET | 5611 | 118.55 |
| 09:55 ET | 1500 | 118.62 |
| 09:57 ET | 1305 | 118.67 |
| 10:00 ET | 4886 | 118.18 |
| 10:02 ET | 1495 | 118.065 |
| 10:04 ET | 2816 | 118.435 |
| 10:06 ET | 3723 | 118.49 |
| 10:08 ET | 10021 | 118.37 |
| 10:09 ET | 600 | 118.52 |
| 10:11 ET | 2700 | 118.285 |
| 10:13 ET | 4553 | 118.38 |
| 10:15 ET | 1400 | 118.33 |
| 10:18 ET | 1400 | 118.0925 |
| 10:20 ET | 1741 | 117.87 |
| 10:22 ET | 1950 | 118.32 |
| 10:24 ET | 2200 | 118.475 |
| 10:26 ET | 1314 | 118.465 |
| 10:27 ET | 3371 | 118.66 |
| 10:29 ET | 7947 | 119.17 |
| 10:31 ET | 1734 | 119.39 |
| 10:33 ET | 3755 | 119.66 |
| 10:36 ET | 2126 | 119.82 |
| 10:38 ET | 8738 | 119.79 |
| 10:40 ET | 2677 | 119.26 |
| 10:42 ET | 8627 | 119.56 |
| 10:44 ET | 1038 | 119.61 |
| 10:45 ET | 4957 | 119.25 |
| 10:47 ET | 4170 | 119.595 |
| 10:49 ET | 2601 | 119.675 |
| 10:51 ET | 300 | 119.775 |
| 10:54 ET | 2954 | 119.545 |
| 10:56 ET | 1300 | 119.52 |
| 10:58 ET | 700 | 119.355 |
| 11:00 ET | 200 | 119.305 |
| 11:02 ET | 3399 | 119.545 |
| 11:05 ET | 816 | 119.5327 |
| 11:07 ET | 1624 | 119.565 |
| 11:09 ET | 400 | 119.72 |
| 11:12 ET | 200 | 119.6 |
| 11:14 ET | 1478 | 119.48 |
| 11:16 ET | 1850 | 119.515 |
| 11:18 ET | 2400 | 119.26 |
| 11:20 ET | 1991 | 119.45 |
| 11:21 ET | 4983 | 119.59 |
| 11:23 ET | 3372 | 119.63 |
| 11:25 ET | 1101 | 119.64 |
| 11:27 ET | 7085 | 119.705 |
| 11:30 ET | 1622 | 119.74 |
| 11:32 ET | 2012 | 119.75 |
| 11:34 ET | 183 | 119.805 |
| 11:36 ET | 769 | 119.7 |
| 11:38 ET | 764 | 119.6829 |
| 11:39 ET | 1440 | 119.565 |
| 11:43 ET | 1851 | 119.32 |
| 11:45 ET | 400 | 118.95 |
| 11:48 ET | 1335 | 118.84 |
| 11:50 ET | 1700 | 119.19 |
| 11:52 ET | 600 | 119.2 |
| 11:54 ET | 1200 | 119.085 |
| 11:56 ET | 530 | 119.095 |
| 11:57 ET | 2800 | 118.94 |
| 11:59 ET | 6900 | 118.59 |
| 12:01 ET | 900 | 118.54 |
| 12:03 ET | 7784 | 118.555 |
| 12:06 ET | 3485 | 118.455 |
| 12:08 ET | 2585 | 118.49 |
| 12:10 ET | 3394 | 118.96 |
| 12:12 ET | 1200 | 118.805 |
| 12:14 ET | 1767 | 118.83 |
| 12:15 ET | 5949 | 118.81 |
| 12:17 ET | 1709 | 118.655 |
| 12:19 ET | 7628 | 118.74 |
| 12:21 ET | 926 | 118.76 |
| 12:24 ET | 200 | 118.745 |
| 12:26 ET | 200 | 118.74 |
| 12:28 ET | 800 | 118.255 |
| 12:30 ET | 1645 | 118.4424 |
| 12:32 ET | 5700 | 118.425 |
| 12:33 ET | 5636 | 118.375 |
| 12:35 ET | 1821 | 118.5 |
| 12:37 ET | 1556 | 118.2 |
| 12:39 ET | 2050 | 118.11 |
| 12:42 ET | 1339 | 118.41 |
| 12:44 ET | 1358 | 118.69 |
| 12:46 ET | 1753 | 118.95 |
| 12:48 ET | 4100 | 118.67 |
| 12:50 ET | 3269 | 118.545 |
| 12:51 ET | 4487 | 118.285 |
| 12:53 ET | 5432 | 118.38 |
| 12:55 ET | 4940 | 118.44 |
| 12:57 ET | 6850 | 118.47 |
| 01:00 ET | 59931 | 118.39 |
Nov 27, 2024
DJ BioNTech Is Maintained at Buy by Canaccord Genuity, from 9:05AM ET on Wednesday Nov 27, 2024 by Dow Jones
9:05AM ET on Wednesday Nov 27, 2024 by Dow Jones
Nov 26, 2024
DJ BioNTech Is Maintained at Neutral by JP Morgan, from 9:51AM ET on Tuesday Nov 26, 2024 by Dow Jones
9:51AM ET on Tuesday Nov 26, 2024 by Dow Jones
Nov 19, 2024
DJ BioNTech Stock Has Been Hit Hard Since RFK Jr.'s Nomination. Why This Analyst Upgraded It. -- Barrons.com, from 11:57AM ET on Tuesday Nov 19, 2024 by Dow Jones
11:57AM ET on Tuesday Nov 19, 2024 by Dow JonesDJ BioNTech Raised to Outperform From In-Line by Evercore ISI Group, from 7:34AM ET on Tuesday Nov 19, 2024 by Dow Jones
7:34AM ET on Tuesday Nov 19, 2024 by Dow Jones*DJ BioNTech Started at Buy by Berenberg, from 1:02AM ET on Tuesday Nov 19, 2024 by Dow Jones
1:02AM ET on Tuesday Nov 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biontech SE | 28.4B | -57.4x | --- |
Beigene Ltd | 22.6B | -26.1x | --- |
Incyte Corp | 14.4B | 533.0x | +39.11% |
Charles River Laboratories International Inc | 10.2B | 24.8x | +15.57% |
United Therapeutics Corp | 16.8B | 16.3x | +8.22% |
argenx SE | 37.6B | -733.0x | --- |
Company Information
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Contact Information
- Headquarters
- An der Goldgrube 12MAINZ, Germany 55131
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Supervisory Board
- Helmut Jeggle
- Chief Executive Officer, Member of the Management Board
- Ugur Sahin
- Independent Deputy Chairman of the Supervisory Board
- Ulrich Wandschneider
- Chief Financial Officer
- Jens Holstein
- Chief Operating Officer, Member of the Management Board
- Sierk Poetting
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $28.4B |
|---|---|
Revenue (TTM) | $3.2B |
Shares Outstanding | 239.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.22 |
EPS | $-2.06 |
Book Value | $89.87 |
P/E Ratio | -57.4x |
Price/Sales (TTM) | 8.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -30.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
